AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.02 EUR | -102.57% |
| 2022 | 0.69 EUR | -37.27% |
| 2021 | 1.10 EUR | 223.53% |
| 2020 | 0.34 EUR | 61.9% |
| 2019 | 0.21 EUR | 384.99% |
| 2018 | 0.04 EUR | -93.13% |
| 2017 | 0.63 EUR | 584.62% |
| 2016 | -0.13 EUR | 72.34% |
| 2015 | -0.47 EUR | -130.92% |
| 2014 | 1.52 EUR | 489.74% |
| 2013 | -0.39 EUR | -225.0% |
| 2012 | -0.12 EUR | 20.0% |
| 2011 | -0.15 EUR | 21.05% |
| 2010 | -0.19 EUR | -90.0% |
| 2009 | -0.10 EUR | -11211.11% |
| 2008 | 0.00 EUR | -99.78% |
| 2007 | 0.40 EUR | 0.0% |
| 2006 | 0.40 EUR | 25.0% |
| 2005 | 0.32 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.11 EUR | 191.67% |
| 2024 Q2 | -0.15 EUR | -236.36% |
| 2023 Q4 | -0.12 EUR | -133.33% |
| 2023 Q1 | -0.14 EUR | -153.85% |
| 2023 FY | - EUR | -102.57% |
| 2023 Q3 | 0.36 EUR | 541.72% |
| 2023 Q2 | -0.08 EUR | 41.79% |
| 2022 Q1 | 0.47 EUR | 42.42% |
| 2022 Q3 | 0.10 EUR | 232.1% |
| 2022 Q2 | -0.08 EUR | -116.11% |
| 2022 Q4 | 0.26 EUR | 160.0% |
| 2022 FY | - EUR | -37.27% |
| 2021 Q3 | 0.36 EUR | 125.0% |
| 2021 Q2 | 0.16 EUR | -36.0% |
| 2021 Q4 | 0.33 EUR | -8.33% |
| 2021 FY | - EUR | 223.53% |
| 2021 Q1 | 0.25 EUR | 327.27% |
| 2020 FY | - EUR | 61.9% |
| 2020 Q1 | 0.10 EUR | -0.7% |
| 2020 Q2 | 0.10 EUR | -1.31% |
| 2020 Q3 | 0.26 EUR | 165.31% |
| 2020 Q4 | -0.11 EUR | -142.31% |
| 2019 Q4 | 0.10 EUR | -60.0% |
| 2019 Q1 | 0.02 EUR | -78.02% |
| 2019 Q3 | 0.25 EUR | 256.25% |
| 2019 FY | - EUR | 384.99% |
| 2019 Q2 | -0.16 EUR | -900.0% |
| 2018 Q1 | 0.14 EUR | -12.5% |
| 2018 FY | - EUR | -93.13% |
| 2018 Q4 | 0.09 EUR | 19.74% |
| 2018 Q3 | 0.08 EUR | 129.23% |
| 2018 Q2 | -0.26 EUR | -285.71% |
| 2017 Q2 | -0.27 EUR | -250.0% |
| 2017 Q1 | 0.18 EUR | 205.88% |
| 2017 FY | - EUR | 584.62% |
| 2017 Q3 | 0.22 EUR | 181.48% |
| 2017 Q4 | 0.16 EUR | -27.27% |
| 2016 Q1 | 0.07 EUR | 141.18% |
| 2016 Q4 | -0.17 EUR | -357.58% |
| 2016 FY | - EUR | 72.34% |
| 2016 Q3 | 0.07 EUR | 186.27% |
| 2016 Q2 | -0.08 EUR | -209.29% |
| 2015 Q4 | -0.17 EUR | -21.43% |
| 2015 Q3 | -0.14 EUR | -215.32% |
| 2015 Q1 | -0.11 EUR | -109.82% |
| 2015 Q2 | -0.04 EUR | 59.64% |
| 2015 FY | - EUR | -130.92% |
| 2014 Q4 | 1.12 EUR | 489.47% |
| 2014 Q1 | 0.09 EUR | -35.71% |
| 2014 Q3 | 0.19 EUR | 441.73% |
| 2014 FY | - EUR | 489.74% |
| 2014 Q2 | -0.06 EUR | -161.78% |
| 2013 Q4 | 0.14 EUR | 366.67% |
| 2013 FY | - EUR | -225.0% |
| 2013 Q3 | 0.03 EUR | 109.68% |
| 2013 Q1 | -0.26 EUR | -189.66% |
| 2013 Q2 | -0.31 EUR | -19.23% |
| 2012 Q4 | 0.29 EUR | 270.59% |
| 2012 FY | - EUR | 20.0% |
| 2012 Q1 | -0.03 EUR | -131.12% |
| 2012 Q2 | -0.21 EUR | -588.52% |
| 2012 Q3 | -0.17 EUR | 19.05% |
| 2011 Q2 | -0.21 EUR | -1589.36% |
| 2011 FY | - EUR | 21.05% |
| 2011 Q1 | 0.01 EUR | 130.45% |
| 2011 Q4 | 0.10 EUR | 290.29% |
| 2011 Q3 | -0.05 EUR | 75.48% |
| 2010 Q4 | -0.05 EUR | -112.51% |
| 2010 Q1 | -0.16 EUR | -45.45% |
| 2010 FY | - EUR | -90.0% |
| 2010 Q2 | -0.35 EUR | -118.75% |
| 2010 Q3 | 0.37 EUR | 205.71% |
| 2009 Q2 | 0.04 EUR | -73.75% |
| 2009 Q3 | -0.12 EUR | -385.71% |
| 2009 FY | - EUR | -11211.11% |
| 2009 Q4 | -0.11 EUR | 8.33% |
| 2009 Q1 | 0.16 EUR | 0.0% |
| 2008 FY | - EUR | -99.78% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 25.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|